Deutsche Bank’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $231K | Sell |
54,110
-219
| -0.4% | -$933 | ﹤0.01% | 2868 |
|
|
2025
Q1 | $204K | Buy |
54,329
+14,998
| +38% | +$56.4K | ﹤0.01% | 2913 |
|
|
2024
Q4 | $229K | Buy |
39,331
+12,199
| +45% | +$71.1K | ﹤0.01% | 2999 |
|
|
2024
Q3 | $324K | Sell |
27,132
-226,742
| -89% | -$2.71M | ﹤0.01% | 2646 |
|
|
2024
Q2 | $2.75M | Buy |
253,874
+4,844
| +2% | +$52.4K | ﹤0.01% | 1471 |
|
|
2024
Q1 | $2.82M | Buy |
249,030
+369
| +0.1% | +$4.18K | ﹤0.01% | 1484 |
|
|
2023
Q4 | $3.49M | Buy |
248,661
+234,143
| +1,613% | +$3.29M | ﹤0.01% | 1394 |
|
|
2023
Q3 | $179K | Sell |
14,518
-234,177
| -94% | -$2.89M | ﹤0.01% | 2834 |
|
|
2023
Q2 | $2.25M | Sell |
248,695
-6,023
| -2% | -$54.4K | ﹤0.01% | 1565 |
|
|
2023
Q1 | $884K | Sell |
254,718
-201,948
| -44% | -$701K | ﹤0.01% | 2167 |
|
|
2022
Q4 | $1.12M | Hold |
456,666
| – | – | ﹤0.01% | 1984 |
|
|
2022
Q3 | $1.26M | Hold |
456,666
| – | – | ﹤0.01% | 1836 |
|
|
2022
Q2 | $1.86M | Buy |
456,666
+400,229
| +709% | +$1.63M | ﹤0.01% | 1804 |
|
|
2022
Q1 | $240K | Sell |
56,437
-50,728
| -47% | -$216K | ﹤0.01% | 3139 |
|
|
2021
Q4 | $1M | Buy |
107,165
+980
| +0.9% | +$9.18K | ﹤0.01% | 2422 |
|
|
2021
Q3 | $2.93M | Buy |
106,185
+7,094
| +7% | +$195K | ﹤0.01% | 1827 |
|
|
2021
Q2 | $2.77M | Buy |
99,091
+85,615
| +635% | +$2.4M | ﹤0.01% | 1926 |
|
|
2021
Q1 | $447K | Buy |
+13,476
| New | +$447K | ﹤0.01% | 3157 |
|